Tenaya Therapeutics
tenayatherapeutics.com
Military
Health Care
Ammunition
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Tenaya Therapeutics, Inc., South San Francisco, CA (+1 more)
Other sponsors in the same field
Insitu 
Mayo Clinic 
Persistent Systems 
NTT DATA
Alert me
US Department of Labor · latest filing May 5, 2025 · Visa details by country
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
RA Capital ManagementVia a fund
GVVia a fund
569 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021
Highly specific HDAC6 inhibitors (HDAC6i) demonstrated improved cardiac function in mouse models of heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM) Potential utility of HDAC6 as a target in heart disease wa
Read more
Report
Tenaya Therapeutics Announces New Appointments to Leadership Team
Gene therapy industry veteran Leone Patterson joins Tenaya as Chief Financial and Business Officer Cardiologist Matthew Pollman appointed as Senior Vice President, Clinical Development SOUTH SAN FRANCISCO, Calif. - Tenaya Therapeutics, a biotechnology com
Read more
Report
Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy
TN-201 is a potentially curative gene therapy intended to address genetic hypertrophic cardiomyopathy (gHCM) caused by mutations in the Myosin Binding Protein C3 (MYBPC3) gene, that is currently in IND-enabling studies. TN-201 has been granted Orphan Drug
Read more
Report
Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease
Read more
Report
Talent, culture, and ethics are all necessary ingredients in the biotech recipe for success
Our CEO, Faraz Ali, spoke with Peter Kaplan for an article in STAT to discuss the core values that are essential for a biotech company's success. Faraz outlined the ways in which strong ethics and the right moral compass are crucial for creating a culture
Read more
Report
Navigating the Complexities of AAV Scale-Up and Manufacturing
Tenaya's senior vice president of manufacturing, Kee-Hong Kim, Ph.D., spoke with John Sterling, editor of Genetic Engineering & Biotechnology News in an executive roundtable interview to discuss the challenges and complexities involved with AAV manufactur
Read more
Report
The heart of market access: opportunities and challenges for cell and gene therapy development for orphan and prevalent cardiovascular diseases
Our CEO, Faraz Ali, authored an article for Cell & Gene Therapy Insights discussing the opportunities and challenges of developing cell and gene therapies for cardiovascular disease. Cardiovascular diseases, especially orphan indications, are vastly under
Read more
Report
Tenaya Therapeutics to Present Preclinical Data at 2020 Annual Meeting of the American Society of Gene & Cell Therapy
SOUTH SAN FRANCISCO, Calif., May 11, 2020 - Tenaya Therapeutics, Inc., a company with a mission to discover, develop, and deliver potentially curative therapies that target the underlying causes of heart disease, today announced that it will present precl
Read more
Report
Tenaya Therapeutics Strengthens Leadership Team with Appointment of Two Biopharmaceutical Industry Veterans
-Company Expands Scientific Advisory Board with Addition of Experts in Cardiovascular Genetics, Gene Therapy and Molecular Biology- South San Francisco, Calif. - March 13, 2019 - Tenaya Therapeutics, a biopharmaceutical company focused on developing poten
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Union City
United States
Regional office
Union City
South San Francisco
United States
Headquarters SSF - 171